In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.

Input: Consider Input: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Regulatory Transparency, Patient 
Access, and Effective Drug Enforcement Act of 2014''.

SEC. 2. SCHEDULING OF SUBSTANCES INCLUDED IN NEW FDA-APPROVED DRUGS.

    Section 201 of the Controlled Substances Act (21 U.S.C. 811) is 
amended by inserting after subsection (h) the following:
    ``(i) Within 45 days of receiving a recommendation from the 
Secretary to add a drug or substance that has never been marketed in 
the United States to a schedule under this title, the Attorney General 
shall, without regard to the findings required by subsection (a) of 
this section or section 202(b), issue an interim final rule, under the 
exception for good cause described in subparagraph (B) of section 
553(b) of title 5, United States Code, placing the drug or substance 
into the schedule recommended by the Secretary. The interim final rule 
shall be made immediately effective under section 553(d)(3) of title 5, 
United States Code.''.

SEC. 3. ENHANCING NEW DRUG DEVELOPMENT.

    Section 302 of the Controlled Substances Act (21 U.S.C. 822) is 
amended by inserting after subsection (g) the following:
    ``(h)(1) A person who submits an application for registration to 
manufacture or distribute a controlled substance in accordance with 
this section may indicate on the registration application that the 
substance will be used only in connection with clinical trials of a 
drug in accordance with section 505(i) of the Federal Food, Drug, and 
Cosmetic Act.
    ``(2) When an application for registration to manufacture or 
distribute a controlled substance includes an indication that the 
controlled substance will be used only in connection with clinical 
trials of a drug in accordance with section 505(i) of the Federal Food, 
Drug, and Cosmetic Act, the Attorney General shall--
            ``(A) make a final decision on the application for 
        registration within 180 days; or
            ``(B) provide notice to the applicant in writing of--
                    ``(i) the outstanding issues that must be resolved 
                in order to reach a final decision on the application; 
                and
                    ``(ii) the estimated date on which a final decision 
                on the application will be made.''.

SEC. 4. REGISTRATION PROCESS UNDER CONTROLLED SUBSTANCES ACT.

    (a) Definitions.--
            (1) Factors as may be relevant to and consistent with the 
        public health and safety.--Section 303 of the Controlled 
        Substances Act (21 U.S.C. 823) is amended by adding at the end 
        the following:
    ``(i) In this section, the phrase `factors as may be relevant to 
and consistent with the public health and safety' means factors that 
are relevant to and consistent with the findings contained in section 
101.''.
            (2) Imminent danger to the public health or safety.--
        Section 304(d) of the Controlled Substances Act (21 U.S.C. 
        824(d)) is amended--
                    (A) by striking ``(d) The Attorney General'' and 
                inserting ``(d)(1) The Attorney General''; and
                    (B) by adding at the end the following:
    ``(2) In this subsection, the phrase `imminent danger to the public 
health or safety' means that, in the absence of an immediate suspension 
order, controlled substances will continue to be distributed or 
dispensed by a registrant who knows or should know through fulfilling 
the obligations of the registrant under this Act, or has reason to 
believe that--
            ``(A) the dispensing is outside the usual course of 
        professional practice;
            ``(B) the distribution or dispensing poses a present or 
        foreseeable risk of adverse health consequences or death due to 
        the abuse or misuse of the controlled substances; or
            ``(C) the controlled substances will continue to be 
        diverted outside of legitimate distribution channels.''.
    (b) Opportunity To Submit Corrective Action Plan Prior to 
Revocation or Suspension.--Subsection (c) of section 304 of the 
Controlled Substances Act (21 U.S.C. 824) is amended--
            (1) by striking the last two sentences;
            (2) by striking ``(c) Before'' and inserting ``(c)(1) 
        Before''; and
            (3) by adding at the end the following:
    ``(2) An order to show cause under paragraph (1) shall--
            ``(A) contain a statement of the basis for the denial, 
        revocation, or suspension, including specific citations to any 
        laws or regulations alleged to be violated by the applicant or 
        registrant;
            ``(B) direct the applicant or registrant to appear before 
        the Attorney General at a time and place stated in the order, 
        but not less than 30 days after the date of receipt of the 
        order; and
            ``(C) notify the applicant or registrant of the opportunity 
        to submit a corrective action plan on or before the date of 
        appearance.
    ``(3) Upon review of any corrective action plan submitted by an 
applicant or registrant pursuant to paragraph (2), the Attorney General 
shall determine whether denial, revocation or suspension proceedings 
should be discontinued, or deferred for the purposes of modification, 
amendment, or clarification to such plan.
    ``(4) Proceedings to deny, revoke, or suspend shall be conducted 
pursuant to this section in accordance with subchapter II of chapter 5 
of title 5, United States Code. Such proceedings shall be independent 
of, and not in lieu of, criminal prosecutions or other proceedings 
under this title or any other law of the United States.
    ``(5) The requirements of this subsection shall not apply to the 
issuance of an immediate suspension order under subsection (d).''.

SEC. 5. REPORT TO CONGRESS ON EFFECTS OF LAW ENFORCEMENT ACTIVITIES ON 
              PATIENT ACCESS TO MEDICATIONS.

    (a) In General.--Not later than 1 year after the date of enactment 
of this Act, the Secretary of Health and Human Services, acting through 
the Commissioner of Food and Drugs and the Director of the Centers for 
Disease Control and Prevention, and in consultation with the 
Administrator of the Drug Enforcement Administration and the Director 
of National Drug Control Policy, shall submit a report to the 
Committees on the Judiciary of the House of Representatives, the 
Committee on Energy and Commerce of the House of Representatives, the 
Committee on the Judiciary of the Senate, and the Committee on Health, 
Education, Labor and Pensions of the Senate identifying--
            (1) obstacles to legitimate patient access to controlled 
        substances;
            (2) issues with diversion of controlled substances; and
            (3) how collaboration between Federal, State, local, and 
        tribal law enforcement agencies and the pharmaceutical industry 
        can benefit patients and prevent diversion and abuse of 
        controlled substances.
    (b) Consultation.--The report under subsection (a) shall 
incorporate feedback and recommendations from the following:
            (1) Patient groups.
            (2) Pharmacies.
            (3) Drug manufacturers.
            (4) Common or contract carriers and warehousemen.
            (5) Hospitals, physicians, and other health care providers.
            (6) State attorneys general.
            (7) Federal, State, local, and tribal law enforcement 
        agencies.
            (8) Health insurance providers and entities that provide 
        pharmacy benefit management services on behalf of a health 
        insurance provider.
            (9) Wholesale drug distributors.

Output: Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014 - Amends the Controlled Substances Act to direct the Attorney General, within 45 days of receiving a recommendation from the Secretary of Health and Human Services (HHS) to add a drug or substance that has never been marketed in the United States to a schedule of controlled substances, to issue an interim final rule under the exception for good cause, placing it into the schedule recommended, effective immediately. Allows a person who submits an application for registration to manufacture or distribute a controlled substance to indicate on the registration application that the substance will be used only in connection with clinical trials of a drug. Requires the Attorney General to: (1) make a final decision on such application within 180 days, or (2) provide written notice to the applicant of the outstanding issues that must be resolved to reach a final decision and the estimated date on which such decision will be made. Defines: (1) "factors as may be relevant to and consistent with the public health and safety," and (2) "imminent danger to the public health or safety." Requires an order to show cause as to why a registration should not be denied, revoked, or suspended to notify the registrant of the opportunity to submit a corrective action plan on or before the date of appearance before the Attorney General. Requires the Attorney General, upon review of any such plan, to determine whether denial, revocation, or suspension proceedings should be discontinued or deferred for purposes of modification or clarification of such plan. Makes these requirements inapplicable to the issuance of an immediate suspension order. Directs the Secretary, acting through the Commissioner of Food and Drugs (FDA) and the Director of the Centers for Disease Control and Prevention (CDC), to identify: (1) obstacles to legitimate patient access to controlled substances; (2) issues with diversion of controlled substances; and (3) how collaboration between federal, state, local, and tribal law enforcement agencies and the pharmaceutical industry can benefit patients and prevent diversion and abuse of controlled substances.


Input: Consider Input: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Vaccinate America's Children through 
Complete Information & Education Act of 2015''.

SEC. 2. ENCOURAGING STATES TO STRENGTHEN ADMINISTRATIVE PROCEDURES 
              RELATED TO NONMEDICAL EXEMPTIONS FROM STATE VACCINATION 
              REQUIREMENTS.

    (a) In General.--Section 1928 of the Social Security Act (42 U.S.C. 
1396s) is amended--
            (1) by redesignating subsection (h) as subsection (i); and
            (2) by inserting after subsection (g) the following new 
        subsection:
    ``(h) Administrative Procedures for Granting Nonmedical 
Exemptions.--
            ``(1) Certification of adoption of procedures.--
                    ``(A) In general.--A State program under this 
                section does not comply with the requirements of this 
                section unless the State certifies to the Secretary 
                that the State has established administrative 
                procedures for granting nonmedical exemptions from 
                State immunization requirements (as defined in 
                subparagraph (B)) that include at least 2 of the 
                prerequisites described in paragraph (2).
                    ``(B) Nonmedical exemption from state immunization 
                requirement.--For purposes of this subsection, the term 
                `nonmedical exemption from State immunization 
                requirements' means any exemption from a State law that 
                requires a child to receive a pediatric vaccine 
                (including school immunization requirements) that is 
                not based on a medical reason.
            ``(2) Nonmedical exemption prerequisites.--The 
        prerequisites for granting a nonmedical exemption from State 
        immunization requirements described in this paragraph are the 
        following:
                    ``(A) The State requires that prior to the 
                exemption being granted, a parent or guardian seeking a 
                nonmedical exemption from State immunization 
                requirements for a child shall discuss the consequences 
                of nonvaccination with the child's pediatrician or 
                other primary care provider and that the discussion is 
                noted in the child's medical record.
                    ``(B) The State requires that prior to the 
                exemption being granted, a parent or guardian seeking a 
                nonmedical exemption from State immunization 
                requirements for a child read and sign a form that 
                discusses the risks of nonvaccination and submits the 
                form to the State.
                    ``(C) The State requires that prior to the 
                exemption being granted, a parent or guardian seeking a 
                nonmedical exemption from State immunization 
                requirements for a child submits to the State a 
                notarized letter describing the parent's or guardian's 
                reasons for seeking the exemption.
                    ``(D) The State requires that all nonmedical 
                exemptions from State immunization requirements shall 
                only be granted for a 1-year period and shall be 
                required to be renewed annually if a parent or guardian 
                of a child wants the exemption to continue for another 
                year.
            ``(3) Penalty.--
                    ``(A) In general.--With respect to a fiscal year, 
                if a State fails to submit the certification required 
                under paragraph (1) or if the administrative procedures 
                established by the State for granting nonmedical 
                exemptions from State immunization requirements do not 
                include at least 2 of the prerequisites described in 
                paragraph (2), the State shall pay the Secretary an 
                amount equal to--
                            ``(i) in the case of a State that is not a 
                        manufacturer of pediatric vaccines, 5 percent 
                        of the value (as determined by the Secretary) 
                        of the vaccines provided to the State under 
                        subsection (b)(2)(A) for that fiscal year; and
                            ``(ii) in the case of a State that is a 
                        manufacturer of pediatric vaccines, 5 percent 
                        of the sum of--
                                    ``(I) the value (as determined by 
                                the Secretary) of any vaccines provided 
                                to the State under subsection (b)(2)(A) 
                                for that fiscal year; and
                                    ``(II) the amount paid to the State 
                                for the fiscal year under subsection 
                                (b)(2)(C).
                    ``(B) Treatment as an overpayment.--A State payment 
                required to be made to the Secretary under subparagraph 
                (A) shall be deemed an overpayment to the State under 
                this title to be disallowed against the State's regular 
                quarterly draw for all spending under section 
                1903(d)(2). Such a disallowance is not subject to a 
                reconsideration under section 1116(e).''.
    (b) Conforming Amendments.--
            (1) Section 1928 of the Social Security Act (42 U.S.C. 
        1396s), as amended by subsection (a), is further amended--
                    (A) in subsection (a)(1)(A), by striking 
                ``subsection (h)(8)'' and inserting ``subsection 
                (i)(8)''; and
                    (B) in subsection (b)(2)(A)(iv), by striking 
                ``subsection (h)(3)'' and inserting ``subsection 
                (i)(3)''.
            (2) Section 609(d) of the Employee Retirement Income 
        Security Act of 1974 (42 U.S.C. 1169(d)) is amended by striking 
        ``section 1928(h)(6)'' and inserting ``section 1928(i)(6)''.
    (c) Effective Date.--The amendments made by this Act shall take 
effect on the date that is 1 year after the date of the enactment of 
this Act.

Output: Vaccinate America's Children through Complete Information &amp; Education Act of 2015 This bill amends title XIX (Medicaid) of the Social Security Act to require a state to certify that it has established, in its pediatric vaccine distribution program, administrative procedures regarding nonmedical exemptions from state immunization requirements. These procedures must include at least two of the following prerequisites for granting a nonmedical exemption:  the child's parent or guardian shall discuss the consequences of nonvaccination with the child's primary care provider, as noted in the child's medical record;  the child's parent or guardian shall read, sign, and submit to the state a form discussing the risks of nonvaccination;  the child's parent of guardian shall submit to the state a notarized letter describing why the exemption is being sought; or  all medical exemptions shall be granted for only a one-year period and shall be required to be renewed annually only if the child's parent or guardian wants the exemption to continue for another year.  A state that does not comply with these requirements is subject to a monetary penalty.


Input: Consider Input: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Guard and Reserve Readiness and 
Retention Act of 2005''.

SEC. 2. ELIGIBILITY FOR RETIRED PAY FOR NON-REGULAR SERVICE.

    (a) Age and Service Requirements.--Subsection (a) of section 12731 
of title 10, United States Code, is amended to read as follows:
    ``(a)(1) Except as provided in subsection (c), a person is 
entitled, upon application, to retired pay computed under section 12739 
of this title, if the person--
            ``(A) satisfies one of the combinations of requirements for 
        minimum age and minimum number of years of service (computed 
        under section 12732 of this title) that are specified in the 
        table in paragraph (2);
            ``(B) performed the last six years of qualifying service 
        while a member of any category named in section 12732(a)(1) of 
        this title, but not while a member of a regular component, the 
        Fleet Reserve, or the Fleet Marine Corps Reserve, except that 
        in the case of a person who completed 20 years of service 
        computed under section 12732 of this title before October 5, 
        1994, the number of years of qualifying service under this 
        subparagraph shall be eight; and
            ``(C) is not entitled, under any other provision of law, to 
        retired pay from an armed force or retainer pay as a member of 
        the Fleet Reserve or the Fleet Marine Corps Reserve.
    ``(2) The combinations of minimum age and minimum years of service 
required of a person under subparagraph (A) of paragraph (1) for 
entitlement to retired pay as provided in such paragraph are as 
follows:

                                                   The minimum years of
                                              service required for that
Age, in years, is at least:                                     age is:
        53.....................................................     34 
        54.....................................................     32 
        55.....................................................     30 
        56.....................................................     28 
        57.....................................................     26 
        58.....................................................     24 
        59.....................................................     22 
        60.....................................................   20''.
    (b) 20-Year Letter.--Subsection (d) of such section is amended by 
striking ``the years of service required for eligibility for retired 
pay under this chapter'' in the first sentence and inserting ``20 years 
of service computed under section 12732 of this title.''.
    (c) Effective Date.--This section and the amendments made by this 
subsection (a) shall take effect on the first day of the first month 
beginning on or after the date of the enactment of this Act and shall 
apply with respect to retired pay payable for that month and subsequent 
months.

SEC. 3. EXPANDED ELIGIBILITY OF SELECTED RESERVE MEMBERS UNDER TRICARE 
              PROGRAM.

    (a) General Eligibility.--Subsection (a) of section 1076d of title 
10, United States Code, is amended--
            (1) by striking ``(a) Eligibility.--A member'' and 
        inserting ``(a) Eligibility.--(1) Except as provided in 
        paragraph (2), a member'';
            (2) by striking ``after the member completes'' and all that 
        follows through ``one or more whole years following such 
        date''; and
            (3) by adding at the end the following new paragraph:
    ``(2) Paragraph (1) does not apply to a member who is enrolled, or 
is eligible to enroll, in a health benefits plan under chapter 89 of 
title 5.''.
    (b) Condition for Termination of Eligibility.--Subsection (b) of 
such section is amended by striking ``(b) Period of Coverage.--(1) 
TRICARE Standard'' and all that follows through ``(3) Eligibility'' and 
inserting ``(b) Termination of Eligibility Upon Termination of 
Service.--Eligibility''.
    (c) Conforming Amendments.--
            (1) Such section is further amended--
                    (A) by striking subsection (e); and
                    (B) by redesignating subsection (g) as subsection 
                (e) and transferring such subsection within such 
                section so as to appear following subsection (d).
            (2) The heading for such section is amended to read as 
        follows:
``Sec. 1076d. TRICARE program: TRICARE standard coverage for members of 
              the selected reserve''.
    (d) Repeal of Obsolete Provision.--Section 1076b of title 10, 
United States Code, is repealed.
    (e) Clerical Amendments.--The table of sections at the beginning of 
chapter 55 of title 10, United States Code, is amended--
            (1) by striking the item relating to section 1076b; and
            (2) by striking the item relating to section 1076d and 
        inserting the following:

``1076d. TRICARE program: TRICARE Standard coverage for members of the 
                            Selected Reserve.''.
    (f) Savings Provision.--Enrollments in TRICARE Standard that are in 
effect on the day before the date of the enactment of this Act under 
section 1076d of title 10, United States Code, as in effect on such 
day, shall be continued until terminated after such day under such 
section 1076d as amended by this section.


Output: Guard and Reserve Readiness and Retention Act of 2005 - Makes an individual eligible for retired pay for non-regular (reserve) military service if such individual: (1) satisfies one of specified combinations of minimum age (between 53 and 60) and years of service (between 20 and 34); (2) performed the last six years of qualifying service in currently authorized categories of military service, but not while a member of a regular component, the Fleet Reserve, or the Fleet Marine Corps Reserve; and (3) is not entitled to any other retirement pay from an armed force or as a member of the Fleet Reserve or Fleet Marine Corps Reserve.

Authorizes a member of the Selected Reserve to enroll for self or self and family coverage under the TRICARE program (a Department of Defense managed health care program).